BizNews Edge: How an "unlawful" Pretoria factory churned out fake weight-loss jabs for years

South Africa's weight loss jab boom has a dark underside. A Pretoria pharmacy, iDexis, was producing roughly 84,500 units of semaglutide a month — more than Novo Nordisk's entire local sales of Ozempic and Wegovy — under the guise of a one-off "compounding" exemption meant for individual patients. Regulators only inspected the premises this year, more than two years after Novo Nordisk first complained, and found no sterile ventilation, no batch records, and no adverse-event tracking. Elsewhere, the Public Investment Corporation has suspended CEO Patrick Dlamini over an alleged Lanseria Airport conflict of interest, its fifth executive suspension in two years.